CPIX
Cumberland Pharmaceuticals Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
4.35
close · 2026-10-29
value
18
cheaper than peers18
quality
10
stronger fundamentals10
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 2.60× | 53 |
| price to book | 3.74× | 47 |
| forward P/E | 31.07× | 8 |
| EV to EBITDA | 103.62× | 6 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 27.6% | 76 |
| return on equity | -14.4% | 37 |
| revenue growth | -98.5% | 1 |
| operating margin | -1898.7% | 1 |
4 of 4 measures available
Facts
| market cap | $65M |
| free cash flow | -$310,025 |
| employees | 93 |
| first trade | 2009-08-11 |
| next earnings | 2026-08-04 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.19 | -0.46 | -0.44 | -0.38 |
| free cash flow | $4.8M | -$791,900 | $5.6M | $6.4M |
| net income | -$2.8M | -$6.5M | -$6.3M | -$5.6M |
| revenue | $44.5M | $37.9M | $39.6M | $42.0M |
| unusual items | $0 | $237,089 | $821,800 | $611,330 |